| Literature DB >> 33583915 |
Abstract
Since the 1970s, luteolytic doses used for synchronizing estrus in dairy cattle have remained unchanged. This study aimed to evaluate the dose-response effect of prostaglandin F2α (PGF2α), which is used for synchronizing estrus, and subsequent fertility in cows with two or more corpora lutea (CL). The study population consisted of 1,683 cows with a single CL (1CL), 501 cows with multiple CL receiving a single dose of PGF2α (2CL1), and 252 cows with multiple CL receiving a 1.5 × PGF2α dose (2CL1.5). Cows with a single CL (n = 1,245) showed estrus significantly (P < 0.01) earlier (3.01 ± 1.23 days; mean ± SD) than cows with multiple CL (n = 287; 3.33 ± 1.69 days). Using 1CL cows as reference, the odds ratio (OR) for the estrus response in 2CL1 cows was 0.13 (P < 0.0001), whereas the ORs for estrus response and pregnancy of 2CL1.5 cows were 1.8 (P = 0.0001) and 1.7 (P = 0.001), respectively. Based on the results for only the 2CL1 cows, the OR for the estrus response was 0.7 (P = 0.01) for cows producing ≥ 45 kg of milk at treatment, compared to the remaining cows producing < 45 kg of milk. Our results showed that the presence of multiple CL reduced the estrus response to that induced by a single PGF2α dose and milk production was inversely associated with this response, whereas an increased PGF2α dose improved the estrus response. Therefore, an increase in the standard PGF2α dose is recommended.Entities:
Keywords: Double ovulation; Luteolysis failure; Prostaglandin analogues
Mesh:
Substances:
Year: 2021 PMID: 33583915 PMCID: PMC8075729 DOI: 10.1262/jrd.2020-144
Source DB: PubMed Journal: J Reprod Dev ISSN: 0916-8818 Impact factor: 2.214
Independent variables recorded at treatment and effects of the different treatments a) on each dependent variable (n = 2,436)
| 1CL (n = 1,683) | 2CL1 (n = 501) | 2CL1.5 (n = 252) | ||
|---|---|---|---|---|
| Independent variables b) | ||||
| Parity (pluriparous) | 1301 (77.3%) | 406 (81%) | 212 (84.1%) | |
| Milk production (≥ 45 kg) | 941 (55.9%) | 302 (60.3%) | 153 (60.7%) | |
| Days in milk (≥ 90 days) | 976 (58%) | 306 (61.1%) | 151 (59.9%) | |
| Season (warm period: May–September) | 572 (34%) | 160 (31.9%) | 81 (32.1%) | |
| Three or four CL | 22 (4.4%) | 13 (5.2%) | ||
| Dependent variables c) | ||||
| Estrus response d) | 1245/1683 (74%) * | 78/501 (15.6%) ** | 209/252 (82.9%) *** | |
| Conception rate e) | 498/1245 (40%) * | 35/78 (44.9%) *,** | 112/209 (53.6%) ** | |
| Days (mean ± SD) f) | 3.01 ± 1.23 * | 3.47 ± 1.69 ** | 3.28 ± 1.25 ** | |
a) 1CL: cows with one corpus luteum (CL) receiving a single PGF2α dose (25 mg dinoprost); 2CL1: cows with two or more CL receiving a single PGF2α dose; 2CL1.5: cows with two or more CL receiving a 1.5 × PGF2α dose (37.5 mg dinoprost). All cows showing estrus were inseminated. b) No significant differences were detected using the chi-square test. c) Values with different superscripts within rows denote significant differences detected using the chi-square test (percentages) or ANOVA and Tukey post-hoc tests (means ± SD). d) In all cows (*–**, **–***: P < 0.0001; *–***: P < 0.001). e) In inseminated cows (*–**: P < 0.01). f) Days from PGF2α treatment to estrus, ranging from 1 to 7 days (*–**: P < 0.01).
Odds ratios for estrus response rate calculated using the final logistic regression model for all cows (n = 2,436) a); for 1CL cows (n = 1,683) b); for 2CL1 cows (n = 501) c); and for 2CL1.5 cows (n = 252)
| Factor | Class | n | % Estrus response | Odds ratio | 95% Confidence interval | P | |
|---|---|---|---|---|---|---|---|
| All cows a) | |||||||
| Season d) | Cool | 1087/1623 | 67 | Reference | |||
| Warm | 445/813 | 54.7 | 0.5 | 0.3–0.8 | 0.004 | ||
| Treatment e) | 1CL | 1245/1683 | 74 | Reference | |||
| 2CL1 | 78/501 | 15.6 | 0.13 | 0.08–0.2 | < 0.0001 | ||
| 2CL1.5 | 209/252 | 82.9 | 1.8 | 1.2–2.5 | 0.0001 | ||
| 1CL cows b) | |||||||
| Season d) | Cool | 858/1111 | 77.2 | Reference | |||
| Warm | 366/572 | 64 | 0.5 | 0.4–0.8 | < 0.001 | ||
| Milk production | < 45 kg | 543/742 | 73.2 | Reference | |||
| ≥ 45 kg | 702/941 | 74.6 | 1.1 | 0.7–1.2 | 0.3 | ||
| 2CL1 cows c) | |||||||
| Season d) | Cool | 55/341 | 16.1 | Reference | |||
| Warm | 23/160 | 14.4 | 0.9 | 0.8–1.2 | 0.5 | ||
| Milk production | < 45 kg | 40/199 | 20.1 | Reference | |||
| ≥ 45 kg | 38/302 | 12.6 | 0.7 | 0.4–0.9 | 0.01 | ||
| 2CL1.5 cows | |||||||
| Season d) | Cool | 143/171 | 83.6 | Reference | |||
| Warm | 66/81 | 81.5 | 0.7 | 0.5–1.1 | 0.7 | ||
| Milk production | < 45 kg | 81/99 | 81.8 | Reference | |||
| ≥ 45 kg | 128/153 | 83.7 | 1.1 | 0.8–1.4 | 0.5 | ||
a) Hosmer and Lemeshow goodness-of-fit = 26.6; 3 df; P = 0.93. R2 Nagelkerke = 0.67. b) Hosmer and Lemeshow goodness-of-fit = 25.6; 3 df; P = 0.90. R2 Nagelkerke = 0.10. c) Hosmer and Lemeshow goodness-of-fit = 25.6; 3 df; P = 0.90. R2 Nagelkerke = 0.10. d) Cool period: October–April; warm period: May–September. e) 1CL: cows with one CL receiving a single PGF2α dose (25 mg dinoprost); 2CL1: cows with two or more CL receiving a single PGF2α dose; 2CL1.5: cows with two or more CL receiving a 1.5 × PGF2α dose (37.5 mg dinoprost).
Association between pregnancy and independent variables included in the final logistic regression model for inseminated cows (n = 1532) a)
| Factor | Class | n | % Pregnancy | Odds ratio | 95% Confidence interval | P |
|---|---|---|---|---|---|---|
| Parity | Primiparous | 175/363 | 48.2 | Reference | ||
| Pluriparous | 470/1169 | 40.2 | 0.7 | 0.5–0.9 | 0.009 | |
| Treatment b) | 1CL | 498/1245 | 40 | Reference | ||
| 2CL1 | 35/78 | 44.9 | 1.2 | 0.8–2.0 | 0.3 | |
| 2CL1.5 | 112/209 | 53.6 | 1.7 | 1.3–2.4 | 0.001 | |
a) Hosmer and Lemeshow goodness-of-fit = 27.6; 3 df; P = 0.91. R2 Nagelkerke = 0.09. b) 1CL: cows with one CL receiving a single PGF2α dose (25 mg dinoprost); 2CL1: cows with two or more CL receiving a single PGF2α dose; 2CL1.5: cows with two or more CL receiving a 1.5 times PGF2α dose (37.5 mg dinoprost).